~~<i id='86567658D7'><strike id='86567658D7'><tt id='86567658D7'><pre id='86567658D7'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

knowledge

leisure time

author：explore 2025-09-28 02:28:17 - browse：346

ARCH Venture Partners, one of the top investors in the biotech ecosystem, is raising $3 billion for a new fund.

The Chicago-based firm filed paperwork with the Securities and Exchange Commission this week for what would be its 13th namesake fund. Arch estimated it would raise around $3 billion — roughly the same amount it raised during its more recent fundraising in 2022.

Arch declined to comment on the new fundraising.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Drug repurposing or repositioning? The language matters
Next article： Bryan Kohberger seeks indictment dismissal in Idaho college killings case

explore

leisure time

explore

Wikipedia

AdobeWhatwillhappenifAmericanslosetheconstitutionalrighttoabortion?Notallwomenwhoneedanabortionwould

WSS

Trader Joe's recalls 10K cases of broccoli cheddar soup over potential foreign material

Senate panel eyes new effort on drug shortages

What to expect at HLTH 2023, the health care industry conference

As the dark side of IVF slowly comes into focus, even more transparency is needed

Moscow blames Kyiv for missile attacks in southern Russia as Kremlin forces pound Ukrainian village

Chan Zuckerberg Biohub Chicago to focus on inflammation

knowledge

leisure time

explore

Hepatitis C has a cure — but many Americans still lack access to it

FDA panel signals lack of confidence in Amgen cancer drug data

Moonlake's readout produced a cash windfall. Risks remain

Bill would stop addiction treatment from triggering child abuse inquiry

Jerome Adams on the need for new antivirals for Covid

Biden jokes that Republicans may impeach him because inflation is starting to cool down

How to save PrEP access — and even expand it

Why Charlie Gard's case is so disturbing to Americans

Virginia high school admissions case could be legal follow

Trump allegedly attempted to have surveillance video deleted: Special Counsel

leisure time

'The boss' wants server deleted: New allegations emerge in Trump indictment

3 questions for the future of Biden's cancer moonshot

Eli Lilly buys Point Biopharma in radiopharmaceuticals play

'The boss' wants server deleted: New allegations emerge in Trump indictment

As the dark side of IVF slowly comes into focus, even more transparency is needed

FDA authorizes Novavax’s updated Covid

explore

Wikipedia

Wikipedia

Wikipedia